• 1
    Stout RD, Suttles J: Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J Leukoc Biol 2004; 76:509513.
  • 2
    Naito M, Hasegawa G, Ebe Y, Yamamoto T: Differentiation and function of Kupffer cells. Med Electron Microsc 2004; 37:1628.
  • 3
    Loutit JF, Nisbet NW: The origin of osteoclasts. Immunobiology 1982; 161:193203.
  • 4
    Abrahams VM, Kim YM, Straszewski SL, Romero R, Mor G: Macrophages and apoptotic cell clearance during pregnancy. Am J Reprod Immunol 2004; 51:275282.
  • 5
    Heikkinen J, Möttönen M, Komi J, Alanen A, Lassila O: Phenotypic characterization of human decidual macrophages. Clin Exp Immunol 2003; 131:498505.
  • 6
    Laskarin G, Kämmerer U, Rukavina D, Thomson AW, Fernandez N, Blois SM: Antigen-presenting cells and materno-fetal tolerance: an emerging role for dendritic cells. Am J Reprod Immunol 2007; 58:255267.
  • 7
    McIntire RH, Ganacias KG, Hunt JS: Programming of human monocytes by the uteroplacental environment. Reprod Sci 2008; 15:437447.
  • 8
    Mizuno M, Aoki K, Kimbara T: Functions of macrophages in human decidual tissue in early pregnancy. Am J Reprod Immunol 1994; 31:180188.
  • 9
    Mues B, Langer D, Zwadlo G, Sorg C: Phenotypic characterization of macrophages in human term placenta. Immunology 1989; 67:303307.
  • 10
    Attwood JT, Munn DH: Macrophage suppression of T cell activation: a potential mechanism of peripheral tolerance. Int Rev Immunol 1999; 18:515525.
  • 11
    Bulmer J, Johnson P: Macrophage populations in the human placenta and amniochorion. Clin Exp Immunol 1984; 57:393403.
  • 12
    Lessin DL, Hunt JS, King CR, Wood GW: Antigen expression by cells near the maternal-fetal interface. Am J Reprod Immunol Microbiol 1988; 16:17.
  • 13
    Gardner L, Moffett A: Dendritic cells in the human decidua. Biol Reprod 2003; 69:14381446.
  • 14
    Blois SM, Alba Soto CD, Tometten M, Klapp BF, Margni RA, Arck PC: Lineage, maturity, and phenotype of uterine murine dendritic cells throughout gestation indicate a protective role in maintaining pregnancy. Biol Reprod 2004; 70:10181023.
  • 15
    Metlay JP, Witmer-Pack MD, Agger R, Crowley MT, Lawless D, Steinman RM: The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies. J Exp Med 1990; 171:17531771.
  • 16
    Dudley D, Baker DM, Hickey MJ, Hickstein DD: Expression of surface antigen and mRNA for the CD11c (alpha X, p150) subunit of the human leukocyte adherence receptor family in hematopoietic cells. Biochem Biophys Res Commun 1989; 160:346353.
  • 17
    Hume DA: Macrophages as APC and the dendritic cell myth. J Immunol 2008; 181:58295835.
  • 18
    Kammerer U, Eggert AO, Kapp M, McLellan AD, Geijtenbeek TBH, Dietl J, Van Kooyk Y, Kampgen E: Unique appearance of proliferating antigen-presenting cells expressing DC-SIGN (CD209) in the decidua of early human pregnancy. Am J Pathol 2003; 162:887896.
  • 19
    Repnik U, Tilburgs T, Roelen DL, Van Der Mast BJ, Kanhai HH, Scherjon S, Claas FH: Comparison of macrophage phenotype between decidua basalis and decidua parietalis by flow cytometry. Placenta 2008; 29:405412.
  • 20
    Ishihara O, Sullivan MH, Elder MG: Differences of metabolism of prostaglandin E2 and F2 alpha by decidual stromal cells and macrophages in culture. Eicosanoids 1991; 4:203207.
  • 21
    Parhar RS, Yagel S, Lala PK: PGE2-mediated immunosuppression by first trimester human decidual cells blocks activation of maternal leukocytes in the decidua with potential anti-trophoblast activity. Cell Immunol 1989; 120:6174.
  • 22
    Munn DH, Shafizadeh E, Attwood JT, Bondarev I, Pashine A, Mellor AL: Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med 1999; 189:13631372.
  • 23
    Munn DH, Zhou M, Attwood JT, Bondarev I, Conway SJ, Marshall B, Brown C, Mellor AL: Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 1998; 281:11911193.
  • 24
    Miwa N, Hayakawa S, Miyazaki S, Myojo S, Sasaki Y, Sakai M, Takikawa O, Saito S: IDO expression on decidual and peripheral blood dendritic cells and monocytes/macrophages after treatment with CTLA-4 or interferon-gamma increase in normal pregnancy but decrease in spontaneous abortion. Mol Hum Reprod 2005; 11:865870.
  • 25
    Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM: M-1/M-2 Macrophages and the Th1/Th2 Paradigm. J Immunol 2000; 164:61666173.
  • 26
    Mantovani A, Sica A, Locati M: Macrophage polarization comes of age. Immunity 2005; 23:344346.
  • 27
    Gordon S: Alternative activation of macrophages. Nat Rev Immunol 2003; 3:2335.
  • 28
    Munder M, Eichmann K, Modolell M: Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype. J Immunol 1998; 160:53475354.
  • 29
    Fenton MJ, Buras JA, Donnelly RP: IL-4 reciprocally regulates IL-1 and IL-1 receptor antagonist expression in human monocytes. J Immunol 1992; 149:12831288.
  • 30
    Chaouat G: The Th1/Th2 paradigm: still important in pregnancy? Semin Immunopathol 2007; 29:95113.
  • 31
    Gustafsson C, Mjösberg J, Matussek A, Geffers R, Matthiesen L, Berg G, Sharma S, Buer J, Ernerudh J: Gene expression profiling of human decidual macrophages: evidence for immunosuppressive phenotype. PLoS ONE 2008; 3:e2078.
  • 32
    Burrows TD, King A, Loke YW: Trophoblast migration during human placental implantation. Hum Reprod Update 1996; 2:307321.
  • 33
    Coffelt SB, Hughes R, Lewis CE: Tumor-associated macrophages: effectors of angiogenesis and tumor progression. Biochim Biophys Acta 2009; 1796:1118.
  • 34
    Smith SD, Dunk CE, Aplin JD, Harris LK, Jones RL: Evidence for immune cell involvement in decidual spiral arteriole remodeling in early human pregnancy. Am J Pathol 2009; 174:19591971.
  • 35
    Plaks V, Birnberg T, Berkutzki T, Sela S, BenYashar A, Kalchenko V, Mor G, Keshet E, Dekel N, Neeman M, Jung S: Uterine DCs are crucial for decidua formation during embryo implantation in mice. J Clin Invest 2008; 118:39543965.
  • 36
    Sugino N, Kashida S, Karube-Harada A, Takiguchi S, Kato H: Expression of vascular endothelial growth factor (VEGF) and its receptors in human endometrium throughout the menstrual cycle and in early pregnancy. Reproduction 2002; 123:379387.
  • 37
    Vuorela P, Hatva E, Lymboussaki A, Kaipainen A, Joukov V, Persico MG, Alitalo K, Halmesmäki E: Expression of vascular endothelial growth factor and placenta growth factor in human placenta. Biol Reprod 1997; 56:489494.
  • 38
    Zhou Y, McMaster M, Woo K, Janatpour M, Perry J, Karpanen T, Alitalo K, Damsky C, Fisher SJ: Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol 2002; 160:14051423.
  • 39
    Maglione DGV, Viglietto G, Delli-Bovi P, Persico MG: Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA 1991; 88:92679271.
  • 40
    Park JE, Chen HH, Winer J, Houck KA, Ferrara N: Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J Biol Chem 1994; 269:2564625654.
  • 41
    Clark DE, Smith SK, Licence D, Evans AL, Charnock-Jones DS: Comparison of expression patterns for placenta growth factor, vascular endothelial growth factor (VEGF), VEGF-B and VEGF-C in the human placenta throughout gestation. J Endocrinol 1998; 159:459467.
  • 42
    Clauss M, Weich H, Breier G, Knies U, Röckl W, Waltenberger J, Risau W: The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological Activities. J Biol Chem 1996; 271:1762917634.
  • 43
    Heil M, Clauss M, Suzuki K, Buschmann IR, Willuweit A, Fischer S, Schaper W: Vascular endothelial growth factor (VEGF) stimulates monocyte migration through endothelial monolayers via increased integrin expression. Eur J Cell Biol 2000; 79:850857.
  • 44
    Selvaraj SK, Giri RK, Perelman N, Johnson C, Malik P, Kalra VK: Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor. Blood 2003; 102:15151524.
  • 45
    Ahmed A, Li XF, Dunk C, Whittle MJ, Rushton DI, Rollason T: Colocalisation of vascular endothelial growth factor and its Flt-1 receptor in human placenta. Growth Factors 1995; 12:235243.
  • 46
    Kendall RL, Wang G, Thomas KA: Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. Biochem Biophys Res Commun 1996; 226:324328.
  • 47
    Shibuya M: Structure and dual function of vascular endothelial growth factor receptor-1 (Flt-1). Int J Biochem Cell Biol 2001; 33:409420.
  • 48
    Levine RJ, Maynard SE, Qian C, Lim K-H, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA: Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350:672683.
  • 49
    Nagamatsu T, Fujii T, Kusumi M, Zou L, Yamashita T, Osuga Y, Momoeda M, Kozuma S, Taketani Y: Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia. Endocrinology 2004; 145:48384845.
  • 50
    Koga K, Osuga Y, Yoshino O, Hirota Y, Ruimeng X, Hirata T, Takeda S, Yano T, Tsutsumi O, Taketani Y: Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia. J Clin Endocrinol Metab 2003; 88:23482351.
  • 51
    Lee MC, Wei SC, Tsai-Wu JJ, Wu CH, Tsao PN: Novel PKC signaling is required for LPS-induced soluble Flt-1 expression in macrophages. J Leukoc Biol 2008; 84:835841.
  • 52
    Hayashi M, Hamada Y, Ohkura T: Elevation of granulocyte-macrophage colony-stimulating factor in the placenta and blood in preeclampsia. Am J Obstet Gynecol 2004; 190:456461.
  • 53
    Girardi G, Yarilin D, Thurman JM, Holers VM, Salmon JE: Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction. J Exp Med 2006; 203:21652175.
  • 54
    Krikun G, Lockwood CJ, Abrahams VM, Mor G, Paidas M, Guller S: Expression of Toll-like receptors in the human decidua. Histol Histopathol 2007; 22:847854.
  • 55
    Ilievski V, Lu SJ, Hirsch E: Activation of Toll-like Receptors 2 or 3 and Preterm Delivery in the Mouse. Reprod Sci 2007; 14:315320.
  • 56
    Kajikawa S, Kaga N, Futamura Y, Kakinuma C, Shibutani Y: Lipoteichoic acid induces preterm delivery in mice. J Pharmacol Toxicol Methods 1998; 39:147154.
  • 57
    Koga K, Cardenas I, Aldo P, Abrahams VM, Peng B, Fill S, Romero R, Mor G: Activation of TLR3 in the trophoblast is associated with preterm delivery. Am J Reprod Immunol 2009; 61:196212.
  • 58
    Wang H, Hirsch E: Bacterially-induced preterm labor and regulation of prostaglandin-metabolizing enzyme expression in mice: the role of toll-like receptor 4. Biol Reprod 2003; 69:19571963.
  • 59
    Thaxton JE, Romero R, Sharma S: TLR9 activation coupled to IL-10 deficiency induces adverse pregnancy outcomes. J Immunol 2009; 183:11441154.
  • 60
    Jones LA, Anthony JP, Henriquez FL, Lyons RE, Nickdel MB, Carter KC, Alexander J, Roberts CW: Toll-like receptor-4-mediated macrophage activation is differentially regulated by progesterone via the glucocorticoid and progesterone receptors. Immunology 2008; 125:5969.
  • 61
    Su L, Sun Y, Ma F, Lü P, Huang H, Zhou J: Progesterone inhibits toll-like receptor 4-mediated innate immune response in macrophages by suppressing NF-kappaB activation and enhancing SOCS1 expression. Immunol Lett 2009; 125:151155.
  • 62
    Youssef RE, Ledingham MA, Bollapragada SS, O’Gorman N, Jordan F, Young A, Norman JE: The role of toll-like receptors (TLR-2 and -4) and triggering receptor expressed on myeloid cells 1 (TREM-1) in human term and preterm Labor. Reprod Sci 2009; 16:843856.
  • 63
    Miller L, Alley EW, Murphy WJ, Russell SW, Hunt JS: Progesterone inhibits inducible nitric oxide synthase gene expression and nitric oxide production in murine macrophages. J Leukoc Biol 1996; 59:442450.
  • 64
    Snider H, Lezama-Davila C, Alexander J, Satoskar AR: Sex hormones and modulation of immunity against leishmaniasis. Neuroimmunomodulation 2009; 16:106113.
  • 65
    Rorman E, Zamir CS, Rilkis I, Ben-David H: Congenital toxoplasmosis--prenatal aspects of Toxoplasma gondii infection. Reprod Toxicol 2006; 21:458472.
  • 66
    Aarnoudse CA, Vallejo JJG, Saeland E, Van Kooyk Y: Recognition of tumor glycans by antigen-presenting cells. Curr Opin Immunol 2006; 18:105111.
  • 67
    Cambi A, Figdor CG: Dual function of C-type lectin-like receptors in the immune system. Curr Opin Cell Biol 2003; 15:539546.
  • 68
    McGreal EP, Martinez-Pomares L, Gordon S: Divergent roles for C-type lectins expressed by cells of the innate immune system. Mol Immunol 2004; 41:11091121.
  • 69
    Chieppa M, Bianchi G, Doni A, Del Prete A, Sironi M, Laskarin G, Monti P, Piemonti L, Biondi A, Mantovani A, Introna M, Allavena P: Cross-linking of the mannose receptor on monocyte-derived dendritic cells activates an anti-inflammatory immunosuppressive program. J Immunol 2003; 171:45524560.
  • 70
    Laskarin G, Cupurdija K, Tokmadzic VS, Dorcic D, Dupor J, Juretic K, Strbo N, Crncic TB, Marchezi F, Allavena P, Mantovani A, Randic L, Rukavina D: The presence of functional mannose receptor on macrophages at the maternal-fetal interface. Hum Reprod 2005; 20:10571066.
  • 71
    Martinez-Pomares L, Reid DM, Brown GD, Taylor PR, Stillion RJ, Linehan SA, Zamze S, Gordon S, Wong SYC: Analysis of mannose receptor regulation by IL-4, IL-10, and proteolytic processing using novel monoclonal antibodies. J Leukoc Biol 2003; 73:604613.
  • 72
    Geijtenbeek TB, Torensma R, Van Vliet SJ, Van Duijnhoven GC, Adema GJ, Van Kooyk Y, Figdor CG: Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 2000; 100:575585.
  • 73
    Soilleux EJ, Morris LS, Leslie G, Chehimi J, Luo Q, Levroney E, Trowsdale J, Montaner LJ, Doms RW, Weissman D, Coleman N, Lee B: Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro. J Leukoc Biol 2002; 71:445457.
  • 74
    Breburda EE, Dambaeva SV, Slukvin II, Golos TG: Selective distribution and pregnancy-specific expression of DC-SIGN at the maternal-fetal interface in the rhesus macaque: DC-SIGN is a putative marker of the recognition of pregnancy. Placenta 2006; 27:1121.
  • 75
    García-Vallejo JJ, Van Liempt E, Da Costa Martins P, Beckers C, Van Het Hof B, Gringhuis SI, Zwaginga JJ, Van Dijk W, Geijtenbeek TB, Van Kooyk Y, Van Die I: DC-SIGN mediates adhesion and rolling of dendritic cells on primary human umbilical vein endothelial cells through LewisY antigen expressed on ICAM-2. Mol Immunol 2008; 45:23592369.
  • 76
    Appelmelk BJ, Van Die I, Van Vliet SJ, Vandenbroucke-Grauls CM, Geijtenbeek TB, Van Kooyk Y: Cutting edge: carbohydrate profiling identifies new pathogens that interact with dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic cells. J Immunol 2003; 170:16351639.
  • 77
    Van Gisbergen KP, Aarnoudse CA, Meijer GA, Geijtenbeek TB, Van Kooyk Y: Dendritic cells recognize tumor-specific glycosylation of carcinoembryonic antigen on colorectal cancer cells through dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin. Cancer Res 2005; 65:59355944.
  • 78
    Samsen A, Bogoevska V, Klampe B, Bamberger AM, Lucka L, Horst AK, Nollau P, Wagener C: DC-SIGN and SRCL bind glycans of carcinoembryonic antigen (CEA) and CEA-related cell adhesion molecule 1 (CEACAM1): recombinant human glycan-binding receptors as analytical tools. Eur J Cell Biol 2010; 89:8794.
  • 79
    Bogoevska V, Horst A, Klampe B, Lucka L, Wagener C, Nollau P: CEACAM1, an adhesion molecule of human granulocytes, is fucosylated by fucosyltransferase IX and interacts with DC-SIGN of dendritic cells via Lewis x residues. Glycobiology 2006; 16:197209.
  • 80
    Bogoevska V, Nollau P, Lucka L, Grunow D, Klampe B, Uotila LM, Samsen A, Gahmberg CG, Wagener C: DC-SIGN binds ICAM-3 isolated from peripheral human leukocytes through Lewis x residues. Glycobiology 2007; 17:324333.
  • 81
    Vićovac Lj, Bozić M, Bojić-Trbojević Z, Golubović S: Carcinoembryonic antigen related molecules in normal and transformed trophoblast. Placenta 2007; 28:8596.
  • 82
    Bürk MR, Troeger C, Brinkhaus R, Holzgreve W, Hahn S: Severely reduced presence of tissue macrophages in the basal plate of pre-eclamptic placentae. Placenta 2001; 22:309316.
  • 83
    Scholz C, Toth B, Santoso L, Kuhn C, Franz M, Mayr D, Jeschke U, Friese K, Schiessl B: Distribution and maturity of dendritic cells in diseases of insufficient placentation. Am J Reprod Immunol 2008; 60:238245.
  • 84
    Lenschow DJ, Walunas TL, Bluestone JA: CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996; 14:233258.
  • 85
    Greenwald RJ, Freeman GJ, Sharpe AH: The B7 family revisited. Annu Rev Immunol 2005; 23:515548.
  • 86
    Van Berkel ME, Oosterwegel MA: CD28 and ICOS: similar or separate costimulators of T cells? Immunol Lett 2006; 105:115122.
  • 87
    Petroff MG, Chen L, Phillips TA, Azzola D, Sedlmayr P, Hunt JS: B7 family molecules are favorably positioned at the human maternal-fetal interface. Biol Reprod 2003; 68:14961504.
  • 88
    Guleria I, Khosroshahi A, Ansari MJ, Habicht A, Azuma M, Yagita H, Noelle RJ, Coyle A, Mellor AL, Khoury SJ, Sayegh MH: A critical role for the programmed death ligand 1 in fetomaternal tolerance. J Exp Med 2005; 202:231237.
  • 89
    Keir ME, Liang SC, Guleria I, Latchman YE, Qipo A, Albacker LA, Koulmanda M, Freeman GJ, Sayegh MH, Sharpe AH: Tissue expression of PD-L1 mediates peripheral T cell tolerance. J Exp Med 2006; 203:883895.
  • 90
    Francisco LM, Salinas VH, Brown KE, Vanguri VK, Freeman GJ, Kuchroo VK, Sharpe AH: PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J Exp Med 2009; 206:30153029.
  • 91
    Sharpe AH, Wherry EJ, Ahmed R, Freeman GJ: The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol 2007; 8:239245.
  • 92
    Nagamatsu T, Schust DJ, Sugimoto J, Barrier BF: Human decidual stromal cells suppress cytokine secretion by allogenic CD4+ T cells via PD-1 ligand interactions. Hum Reprod 2009; 24:31603171.
  • 93
    Taglauer ES, Trikhacheva AS, Slusser JG, Petroff MG: Expression and function of PDCD1 at the human maternal-fetal interface. Biol Reprod 2008; 79:562569.
  • 94
    Sica GL, Choi IH, Zhu G, Tamada K, Wang SD, Tamura H, Chapoval AI, Flies DB, Bajorath J, Chen L: B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity 2003; 18:849861.
  • 95
    Kryczek I, Zou L, Rodriguez P, Zhu G, Wei S, Mottram P, Brumlik M, Cheng P, Curiel T, Myers L, Lackner A, Alvarez X, Ochoa A, Chen L, Zou W: B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. J Exp Med 2006; 203:871881.
  • 96
    Kryczek I, Wei S, Zou L, Zhu G, Mottram P, Xu H, Chen L, Zou W: Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells. J Immunol 2006; 177:4044.
  • 97
    Wicherek L, Basta P, Pitynski K, Marianowski P, Kijowski J, Wiatr J, Majka M: The characterization of the subpopulation of suppressive B7H4(+) macrophages and the subpopulation of CD25(+) CD4(+) and FOXP3(+) regulatory T-cells in decidua during the secretory cycle phase, Arias Stella reaction, and spontaneous abortion – a preliminary report. Am J Reprod Immunol 2009; 61:303312.
  • 98
    Sasaki Y, Sakai M, Miyazaki S, Higuma S, Shiozaki A, Saito S: Decidual and peripheral blood CD4+ CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol Hum Reprod 2004; 10:347353.
  • 99
    Aluvihare VR, Kallikourdis M, Betz AG: Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 2004; 5:266271.
  • 100
    Mackler AM, Iezza G, Akin MR, McMillan P, Yellon SM: Macrophage trafficking in the uterus and cervix precedes parturition in the mouse. Biol Reprod 1999; 61:879883.
  • 101
    Sakamoto Y, Moran P, Bulmer JN, Searle RF, Robson SC: Macrophages and not granulocytes are involved in cervical ripening. J Reprod Immunol 2005; 66:161173.
  • 102
    Young A, Thomson AJ, Ledingham M, Jordan F, Greer IA, Norman JE: Immunolocalization of proinflammatory cytokines in myometrium, cervix, and fetal membranes during human parturition at term. Biol Reprod 2002; 66:445449.
  • 103
    Osman I, Young A, Ledingham MA, Thomson AJ, Jordan F, Greer IA, Norman JE: Leukocyte density and pro-inflammatory cytokine expression in human fetal membranes, decidua, cervix and myometrium before and during labour at term. Mol Hum Reprod 2003; 9:4145.
  • 104
    Amy GB, Rita SL, Jerome FS III: Mechanisms underlying “functional” progesterone withdrawal at parturition. Ann N Y Acad Sci 2004; 1034:3649.
  • 105
    Shynlova O, Tsui P, Dorogin A, Lye SJ: Monocyte chemoattractant protein-1 (CCL-2) integrates mechanical and endocrine signals that mediate term and preterm labor. J Immunol 2008; 181:14701479.
  • 106
    Christiaens I, Zaragoza DB, Guilbert L, Robertson SA, Mitchell BF, Olson DM: Inflammatory processes in preterm and term parturition. J Reprod Immunol 2008; 79:5057.
  • 107
    Chwalisz K, Benson M, Scholz P, Daum J, Beier HM, Hegele-Hartung C: Pregnancy: cervical ripening with the cytokines interleukin 8, interleukin 1β and tumour necrosis factor α in guinea-pigs. Hum Reprod 1994; 9:21732181.
  • 108
    MacMicking J, Xie Q-w, Nathan C: Nitric oxide and macrophage function. Annu Rev Immunol 1997; 15:323350.
  • 109
    Chwalisz K, Shao-Qing S, Garfield RE, Beier HM: Cervical ripening in guinea-pigs after a local application of nitric oxide. Hum Reprod 1997; 12:20932101.
  • 110
    Buhimschi I, Ali M, Jain V, Chwalisz K, Garfield RE: Pregnancy: differential regulation of nitric oxide in the rat uterus and cervix during pregnancy and labour. Hum Reprod 1996; 11:17551766.
  • 111
    Thomson AJ, Lunan CB, Ledingham M, Howat RC, Cameron IT, Greer IA, Norman JE: Randomised trial of nitric oxide donor versus prostaglandin for cervical ripening before first-trimester termination of pregnancy. Lancet 1998; 352:10931096.
  • 112
    Ledingham MA, Thomson AJ, Young A, Macara LM, Greer IA, Norman JE: Changes in the expression of nitric oxide synthase in the human uterine cervix during pregnancy and parturition. Mol Hum Reprod 2000; 6:10411048.
  • 113
    Mori M, Gotoh T: Regulation of nitric oxide production by arginine metabolic enzymes. Biochem Biophys Res Commun 2000; 275:715719.
  • 114
    Romero R, Espinoza J, Chaiworapongsa T, Kalache K: Infection and prematurity and the role of preventive strategies. Semin Neonatol 2002; 7:259274.
  • 115
    Diamond AK, Sweet LM, Oppenheimer KH, Bradley DF, Phillippe M: Modulation of monocyte chemotactic protein-1 expression during lipopolysaccharide-induced preterm delivery in the pregnant mouse. Reprod Sci 2007; 14:548559.
  • 116
    Esplin MS, Peltier MR, Hamblin S, Smith S, Fausett MB, Dildy GA, Branch DW, Silver RM, Adashi EY: Monocyte chemotactic protein-1 expression is increased in human gestational tissues during term and preterm labor. Placenta 2005; 26:661671.
  • 117
    Chaiworapongsa T, Romero R, Espinoza J, Kim YM, Edwin S, Bujold E, Gomez R, Kuivaniemi H: Macrophage migration inhibitory factor in patients with preterm parturition and microbial invasion of the amniotic cavity. J Matern Fetal Neonatal Med 2005; 18:405416.
  • 118
    Abrahams VM, Visintin I, Aldo PB, Guller S, Romero R, Mor G: A role for TLRs in the regulation of immune cell migration by first trimester trophoblast cells. J Immunol 2005; 175:80968104.
  • 119
    Nakada E, Walley KR, Nakada T, Hu Y, Von Dadelszen P, Boyd JH: Toll-like receptor-3 stimulation upregulates sFLT-1 production by trophoblast cells. Placenta 2009; 30:774779.